ES8604135A1 - Un procedimiento para la preparacion de nuevos 16-fluor-16, 17-dideshidro prostanoides - Google Patents
Un procedimiento para la preparacion de nuevos 16-fluor-16, 17-dideshidro prostanoidesInfo
- Publication number
- ES8604135A1 ES8604135A1 ES543776A ES543776A ES8604135A1 ES 8604135 A1 ES8604135 A1 ES 8604135A1 ES 543776 A ES543776 A ES 543776A ES 543776 A ES543776 A ES 543776A ES 8604135 A1 ES8604135 A1 ES 8604135A1
- Authority
- ES
- Spain
- Prior art keywords
- formula
- reaction
- radicals
- control
- prostanoids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title abstract 2
- 229940127293 prostanoid Drugs 0.000 title 1
- 150000003814 prostanoids Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000002496 gastric effect Effects 0.000 abstract 2
- 208000025865 Ulcer Diseases 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 230000010339 dilation Effects 0.000 abstract 1
- 230000005906 menstruation Effects 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- 239000011541 reaction mixture Substances 0.000 abstract 1
- 238000010992 reflux Methods 0.000 abstract 1
- 230000001850 reproductive effect Effects 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
- 231100000397 ulcer Toxicity 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/337—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0033—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing sulfur
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
- Pyrane Compounds (AREA)
- Pyrrole Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
PROCEDIMIENTO PARA LA OBTENCION DE 16-FLUOR-16,17-DIDESHIDRO PROSTANOIDES Y DE SUS SALES FISIOLOGICAMENTE COMPATIBLES, DE FORMULA (I), EN LA QUE A, R Y R1-R7 PUEDEN SER VARIOS TIPOS DE RADICALES; Y M VALE 1-3. CONSISTE EN LA REACCION DE UN COMPUESTO DE FORMULA (II), EN LA QUE R3, R4, R5 Y R6 PUEDEN SER VARIOS RADICALES Y LOS DEMAS SIMBOLOS TIENEN EL MISMO SIGNIFICADO QUE EN LA FORMULA (I), CON UN REACTIVO DE WITTING, QUE CONTIENE UN GRUPO -(CH2)4-COR, DONDE R ES EL MISMO QUE EN LA FORMULA (I). LA REACCION SE EFECTUA EN UN DISOLVENTE ORGANICO INERTE, EN PRESENCIA DE UNA BASE, A UNA TEMPERATURA COMPRENDIDA ENTRE 0JC Y LA DE REFLUJO DE LA MEZCLA DE REACCION. ESTOS COMPUESTOS TIENEN APLICACIONES PARA EL CONTROL DEL CICLO REPRODUCTOR EN LA MENSTRUACION PARA PRODUCIR LA DILATACION CERVICAL PARA GINECOLOGIAS Y OBSTETRICIAS, PARA CONTROLAR LA SECRECION GASTRICA Y REDUCIR LA FORMACION DE ULCERAS GASTROINTESTINALES.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB838324004A GB8324004D0 (en) | 1983-09-07 | 1983-09-07 | 16-fluoro-16 17-didehydro prostanoids |
Publications (2)
Publication Number | Publication Date |
---|---|
ES543776A0 ES543776A0 (es) | 1986-01-16 |
ES8604135A1 true ES8604135A1 (es) | 1986-01-16 |
Family
ID=10548451
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES535551A Expired ES8607022A1 (es) | 1983-09-07 | 1984-08-30 | Un procedimiento para la preparacion de nuevos 16-fluor-16,17-dideshidro prostanoides. |
ES543776A Expired ES8604135A1 (es) | 1983-09-07 | 1985-05-31 | Un procedimiento para la preparacion de nuevos 16-fluor-16, 17-dideshidro prostanoides |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES535551A Expired ES8607022A1 (es) | 1983-09-07 | 1984-08-30 | Un procedimiento para la preparacion de nuevos 16-fluor-16,17-dideshidro prostanoides. |
Country Status (24)
Country | Link |
---|---|
US (1) | US4626597A (es) |
JP (1) | JPS6072859A (es) |
KR (1) | KR850002830A (es) |
AU (1) | AU562725B2 (es) |
BE (1) | BE900414A (es) |
CH (1) | CH662114A5 (es) |
CS (1) | CS259869B2 (es) |
DE (1) | DE3430626A1 (es) |
DK (1) | DK406484A (es) |
ES (2) | ES8607022A1 (es) |
FI (1) | FI843285A (es) |
FR (1) | FR2551436B1 (es) |
GB (2) | GB8324004D0 (es) |
GR (1) | GR80204B (es) |
HU (1) | HU192430B (es) |
IL (1) | IL72749A (es) |
IT (1) | IT1180210B (es) |
NL (1) | NL8402666A (es) |
NO (1) | NO843355L (es) |
NZ (1) | NZ209294A (es) |
PT (1) | PT79113B (es) |
SE (1) | SE8404334L (es) |
SU (1) | SU1442070A3 (es) |
ZA (1) | ZA846580B (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8625326D0 (en) * | 1986-10-22 | 1986-11-26 | Glaxo Group Ltd | Medicaments |
US5317032A (en) * | 1987-10-02 | 1994-05-31 | Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo | Prostaglandin cathartic |
ES2051862T3 (es) * | 1987-10-02 | 1994-07-01 | Ueno Seiyaku Oyo Kenkyujo Kk | Un metodo para producir un medicamento que tiene un efecto catartico. |
AU616564B2 (en) * | 1988-09-29 | 1991-10-31 | Sumitomo Chemical Company, Limited | Novel pyrazole compounds, method for production thereof, use thereof and intermediates for production thereof |
US5099644A (en) * | 1990-04-04 | 1992-03-31 | General Electric Company | Lean staged combustion assembly |
WO1998021181A2 (en) * | 1996-11-12 | 1998-05-22 | Alcon Laboratories, Inc. | 15-fluoro prostaglandins as ocular hypotensives |
US6680339B2 (en) | 1996-11-12 | 2004-01-20 | Alcon Manufacturing, Ltd. | 15-fluoro prostaglandins as ocular hypotensives |
CN1639117A (zh) * | 2002-03-01 | 2005-07-13 | 阿勒根公司 | 前列腺酰胺的制备 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3987087A (en) * | 1971-07-29 | 1976-10-19 | The Upjohn Company | Phenyl-substituted prostaglandin-f type analogs |
GB1396206A (en) * | 1972-04-27 | 1975-06-04 | Upjohn Co | Prostaglandins and the preparation thereof |
ZA744580B (en) * | 1973-07-20 | 1975-07-30 | Upjohn Co | Prostaglandin analogs |
US4059576A (en) * | 1973-08-06 | 1977-11-22 | Hoffmann-La Roche, Inc. | 11-Substituted prostaglandins |
GB1484591A (en) * | 1974-04-11 | 1977-09-01 | Ono Pharmaceutical Co | Prostaglandin compositions |
AU501803B2 (en) * | 1975-03-21 | 1979-06-28 | Farmitalia Carlo Erba S.P.A. | Fluoro-prostaglandins |
US4268522A (en) * | 1976-06-14 | 1981-05-19 | Pfizer Inc. | 13,14-Dihydro-15-alkenyl- and 13,14-dihydro-15-alkynyl prostaglandins and analogs thereof |
US4283417A (en) * | 1976-06-14 | 1981-08-11 | Pfizer Inc. | Bronchodialation with 13,14-dihydro-15-alkenyl prostaglandins |
-
1983
- 1983-09-07 GB GB838324004A patent/GB8324004D0/en active Pending
-
1984
- 1984-08-01 IT IT22159/84A patent/IT1180210B/it active
- 1984-08-20 GB GB08421124A patent/GB2146325B/en not_active Expired
- 1984-08-20 DE DE19843430626 patent/DE3430626A1/de not_active Withdrawn
- 1984-08-20 FI FI843285A patent/FI843285A/fi not_active Application Discontinuation
- 1984-08-21 FR FR8413013A patent/FR2551436B1/fr not_active Expired
- 1984-08-21 NZ NZ209294A patent/NZ209294A/en unknown
- 1984-08-21 AU AU32231/84A patent/AU562725B2/en not_active Ceased
- 1984-08-22 US US06/643,014 patent/US4626597A/en not_active Expired - Fee Related
- 1984-08-22 CH CH4020/84A patent/CH662114A5/de not_active IP Right Cessation
- 1984-08-22 IL IL72749A patent/IL72749A/xx unknown
- 1984-08-22 CS CS846360A patent/CS259869B2/cs unknown
- 1984-08-22 PT PT79113A patent/PT79113B/pt unknown
- 1984-08-22 NO NO843355A patent/NO843355L/no unknown
- 1984-08-23 ZA ZA846580A patent/ZA846580B/xx unknown
- 1984-08-23 BE BE0/213533A patent/BE900414A/fr not_active IP Right Cessation
- 1984-08-24 GR GR80204A patent/GR80204B/el unknown
- 1984-08-24 DK DK406484A patent/DK406484A/da not_active Application Discontinuation
- 1984-08-24 KR KR1019840005144A patent/KR850002830A/ko not_active Application Discontinuation
- 1984-08-28 JP JP59177631A patent/JPS6072859A/ja active Pending
- 1984-08-30 ES ES535551A patent/ES8607022A1/es not_active Expired
- 1984-08-30 SE SE8404334A patent/SE8404334L/xx not_active Application Discontinuation
- 1984-08-31 NL NL8402666A patent/NL8402666A/nl not_active Application Discontinuation
- 1984-08-31 HU HU843291A patent/HU192430B/hu unknown
-
1985
- 1985-05-31 ES ES543776A patent/ES8604135A1/es not_active Expired
- 1985-10-10 SU SU853961258A patent/SU1442070A3/ru active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8700254A1 (es) | Un procedimiento para la preparacion de aminoalcoxibenzopiranonas. | |
ES8604135A1 (es) | Un procedimiento para la preparacion de nuevos 16-fluor-16, 17-dideshidro prostanoides | |
ES8705411A1 (es) | Procedimiento para preparar derivados de 1-piperazinacarboxamida | |
ES8505999A1 (es) | Metodo de preparacion de teofilinas 7-substituidas | |
JPS5612377A (en) | Novel thiazole derivative, its preparation, and drug for ulcer having andigestive action | |
JPS5271444A (en) | Synthesis of phenyl-onn-azoxycyanides | |
JPS5283315A (en) | Purification of acetic acid | |
FR2359133A1 (fr) | Procede de preparation de (vinyl 2,2-disubstitue)-g-butyrolactones | |
ES2012695A6 (es) | Un procedimiento para la preparacion de 4-(6'-metoxi -2'- naftil)-but-3-en -2-ona. | |
ES2012173A6 (es) | Procedimiento para la preparacion de un derivado de butanona. | |
ES462844A1 (es) | Un procedimiento para la preparacion de compuestos imidazo (1,5-a) (1,4)diacepinicos. | |
ES399223A1 (es) | Un procedimiento de preparacion de compuestos pirrolidino- na. | |
ES2004876A6 (es) | Un nuevo procedimiento para la preparacion de 4-(6' -metoxi-2' -naftil)butan-2-ona". | |
JPS5225785A (en) | Preparation of 2-substituted-4- trichloromethyl-6-trifluoromethyl-s- t riazines | |
ES459400A1 (es) | Un procedimiento para la produccion de nuevos compuestos de 6,11-dihidrodibenzo (b.e.) tiepin-11-ona. | |
ES444195A1 (es) | Un procedimiento para la preparacion de acido clavulanico. | |
ES457708A1 (es) | Un procedimiento para la preparacion de un compuesto de 3- hidroximetil-2-cefem. | |
ES8303286A1 (es) | Un procedimiento para la preparacion de una n-alquildifenilamina. | |
FR2434142A1 (fr) | Procede de preparation d'amino-hydroxyanthraquinones | |
ES8202807A1 (es) | Un procedimiento para la obtencion de alquil-furanos. | |
JPS5283346A (en) | Synthesis of 4-n-alkoxy-alpha-methylcinnamic acid-4'-cyanophenyl ester | |
JPS51128988A (en) | Process for preparing quinazolone compounds | |
JPS5585568A (en) | Quinolinone-imine derivative and its preparation | |
JPS5210296A (en) | A process for preparing 6,2'-cyclo-5- substituted isocytidines | |
ES8103087A1 (es) | Un procedimiento de preparacion de biotina |